M3 Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Itaru Tanimura

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	23.7yrs
CEO ownership	2.9%
Management average tenure	no data
Board average tenure	5.3yrs

Recent management updates

Recent updates

M3's (TSE:2413) Dividend Will Be Increased To ¥21.00

Mar 07

Is M3, Inc. (TSE:2413) Worth JP¥2.1k Based On Its Intrinsic Value?

Feb 28

CEO

Itaru Tanimura (58 yo)

23.7yrs

Tenure

Mr. Itaru Tanimura was Outside Director of Enigmo Inc. from 2019 to 2022. He has been the President of M3, Inc. since September 2000. Mr. Tanimura was Partner/Joint Manager of McKinsey & Co. since December...

Board Members

Name	Position	Tenure	Compensation	Ownership
Itaru Tanimura	President & Representative Director	23.7yrs	no data	2.87% ¥ 32.2b
Akihiko Tomaru	Director	11.9yrs	JP¥114.00m	no data
Kenichiro Yoshida	External Director	23.7yrs	no data	no data
Ryoko Toyama	Outside Director and Audit & Supervisory Committee Member	no data	no data	no data
Rie Nakamura	Director	1.9yrs	no data	no data
Eiji Tsuchiya	Director	7.9yrs	no data	no data
Kazuyuki Izumiya	Director	5.8yrs	no data	no data
Mayuka Yamazaki	Outside Director and Audit & Supervisory Committee Member	5.3yrs	no data	no data
Takako Ebata	Outside Director and Audit & Supervisory Committee Member	1.9yrs	no data	no data
Yoshinao Tanaka	Director	less than a year	no data	no data
Satoshi Yamazaki	Director	less than a year	no data	no data
Yusuke Tsugawa	Independent External Director	less than a year	no data	no data

5.3yrs

Average Tenure

58yo

Average Age

Experienced Board: 2413's board of directors are considered experienced (5.3 years average tenure).

M3 Management

Management criteria checks 1/4

Key information

Recent management updates

M3, Inc., Annual General Meeting, Jun 26, 2024

No independent directors

No independent directors

Recent updates

Full year 2024 earnings: EPS misses analyst expectations

M3, Inc., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥21.00 per share

M3's (TSE:2413) Dividend Will Be Increased To ¥21.00

Dividend increased to JP¥21.00

M3, Inc. to Report Fiscal Year 2024 Results on Apr 26, 2024

Is M3, Inc. (TSE:2413) Worth JP¥2.1k Based On Its Intrinsic Value?

Now 21% overvalued

Price target decreased by 7.9% to JP¥2,762

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

M3, Inc. to Report Q3, 2024 Results on Jan 31, 2024

Price target decreased by 8.7% to JP¥3,000

Price target decreased by 7.7% to JP¥3,158

M3, Inc. (TSE:2413) entered into a share tender agreement to acquire a 55% stake in Benefit One Inc. (TSE:2412) from Pasona Group Inc. (TSE:2168) and others for approximately ¥140 billion.

Price target decreased by 7.3% to JP¥3,241

Price target decreased by 7.1% to JP¥3,422

Second quarter 2024 earnings: EPS exceeds analyst expectations

M3, Inc. Provides Consolidated Earnings Guidance for the Full Fiscal Year Ending March 31, 2024

M3, Inc. to Report Q2, 2024 Results on Oct 27, 2023

M3, Inc. (TSE:2413) acquired Messly Limited.

M3, Inc. (TSE:2413) acquired frogwell corporation.

M3, Inc. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and the Full Year Ending March 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

M3, Inc. to Report Q1, 2024 Results on Jul 28, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of JP¥19.00 per share at 0.5% yield

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

M3, Inc. (TSE:2413) acquired Michael Allen Company.

M3, Inc. to Report Q3, 2023 Results on Feb 03, 2023

No independent directors

Second quarter 2023 earnings released: EPS: JP¥18.38 (vs JP¥36.86 in 2Q 2022)

M3, Inc. (TSE:2413) acquired Rinkai Medical Service.

M3, Inc. to Report Q2, 2023 Results on Nov 02, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: JP¥19.87 (vs JP¥23.23 in 1Q 2022)

Investor sentiment improved over the past week

M3, Inc. (TSE:2413) acquired Edoctores Soluciones.

M3, Inc. to Report Q1, 2023 Results on Jul 27, 2022

Price target decreased to JP¥5,358

Full year 2022 earnings: EPS misses analyst expectations

M3, Inc. Announces Dividend for the Year Ended March 31, 2022, Payable on June 13, 2022

No independent directors

M3, Inc. to Report Q4, 2022 Results on Apr 27, 2022

Upcoming dividend of JP¥16.00 per share

Price target decreased to JP¥6,353

M3, Inc. Reaffirms Dividend Guidance For Year End March 31, 2022

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

M3, Inc. (TSE:2413) acquired remaining stake in MirVracha LLC.

Price target decreased to JP¥6,953

M3, Inc. (TSE:2413) acquired 3H Holdings, 3H Medi Solution and 3H Clinical Trial.

Second quarter 2022 earnings released: EPS JP¥36.86 (vs JP¥12.15 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥23.23 (vs JP¥9.53 in 1Q 2021)

M3, Inc. Not Provides Earnings Guidance for the Year Ending March 31, 2022

Full year 2021 earnings released: EPS JP¥55.73 (vs JP¥31.89 in FY 2020)

Upcoming dividend of JP¥12.00 per share

M3, Inc. to Report Fiscal Year 2021 Results on Apr 23, 2021

New 90-day low: JP¥8,354

Third quarter 2021 earnings released: EPS JP¥17.68 (vs JP¥9.97 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to JP¥9,644

M3, Inc. (TSE:2413) acquired Towa Sangyo Co.,Ltd.

M3, Inc. to Report Q3, 2021 Results on Jan 29, 2021

M3, Inc. to Report Q2, 2021 Results on Oct 30, 2020

M3, Inc. to Report Q1, 2021 Results on Jul 29, 2020

CEO

Tenure

Board Members

Average Tenure

Average Age